(PDF) Intravitreal Ranibizumab for Diabetic Macular Edema

Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment

Ophthalmology - Netherlands

doi 10.1016/j.ophtha.2012.08.022

Full Text

Abstract

Available in full text

Categories

Date

November 1, 2012

Authors

Michael J. Elman

Lloyd Paul Aiello

Neil M. Bressler

Frederick L. Ferris

Adam R. Glassman

Publisher

Elsevier BV

Related search

Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment: 5-Year Randomized Trial Results

English

Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema

American Journal of Ophthalmology

English

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

Acta Ophthalmologica

English

Expanded 2-Year Follow-Up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

English

Macular Laser Grid Alone Versus Combined With Intravitreal Triamcinolone Plus Bevacizumab for Diabetic Macular Edema

Journal of Pharmaceutical and Scientific Innovation

English

Pss34 - Cost-Effectiveness of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema in Spain

Value in Health

Occupational Health

English

Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema

JAMA Ophthalmology

English

Combined Vitrectomy and Intravitreal Injection Versus Combined Laser and Injection for Treatment of Intractable Diffuse Diabetic Macular Edema

Clinical Ophthalmology

English

Comparison of Natural Course, Intravitreal Triamcinolone and Macular Laser Photocoagulation for Treatment of Mild Diabetic Macular Edema

International Journal of Medical Sciences

English